Sunshine In Your Pocket: Mobile Apps Help Docs Track Drug Firm Payments
Executive Summary
CMS equips doctors to follow their payments from drug manufacturers so discrepancies can be found early and disagreements resolved prior to submission of the data, which companies began collecting Aug. 1.
You may also be interested in...
Sunshine Act Payment Comparisons Likely Cloudy Due To Disclosure Judgment Calls
Some answers to industry questions about ambiguity in sunshine regulations may come through enforcement actions, Sidley Austin’s James Stansel says.
“Sunshine” Might Bring Public Awareness Campaign On Medical Research
Final CMS reg on reporting industry payments to physicians include limiting coverage to companies operating in the U.S. and a definition of third-party payments; despite wins in the revisions from the proposed rule, industry may need a widespread education campaign in order to preserve the value of its physician relationships.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.